Home › Dermatomyositis › Arizona › Phoenix
Dermatomyositis clinical trials in Phoenix, AZ
3 studies for Dermatomyositis are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
RecruitingPhase 3
- Research Site, Phoenix
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
RecruitingPhase 3
- Neuromuscular Research Center, Phoenix
- Mayo Clinic Hospital, Phoenix
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- Mayo Clinic, Phoenix
Dermatomyositis trials in other cities
- Durham, NC8 studies
- Washington, DC7 studies
- Boston, MA5 studies
- New York City, NY5 studies
- Houston, TX5 studies
- Pittsburgh, PA5 studies
- Baltimore, MD4 studies
- Miami, FL4 studies
- Philadelphia, PA4 studies
- Kansas City, KS3 studies
- Aurora, CO3 studies
- Jacksonville, FL3 studies
Other studies in Phoenix
- Breast Cancer25 studies
- Colorectal Cancer25 studies
- Obesity23 studies
- Non-Small Cell Lung Cancer21 studies
- Metastatic Cancer20 studies
- Heart Failure18 studies
- Cancer (all types)18 studies
- Prostate Cancer17 studies
- Pancreatic Cancer17 studies
- Cardiovascular Disease16 studies
- Multiple Myeloma16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.